Mark V Sherrid
20PUBLICATIONS
91CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (20)
Sort by Publication Date:
|Mar 25, 2026
Evolution and Transformation of Hypertrophic Cardiomyopathy From a High Risk to a Treatable Low Mortality Disease With Contemporary Clinical Research Strategies.Barry J Maron, Steven R Ommen, Rick A Nishimura
|Jan 15, 2026
Letter to the editor concerning: Catastrophic apical ballooning in obstructive hypertrophic cardiomyopathy patient treated with mavacamten.Mark V Sherrid, Bette Kim, Daniele Massera
|Dec 17, 2025
Left Atrial Appendage Thrombus in Hypertrophic Cardiomyopathy With Atrial Fibrillation-Common and Resistant to Treatment.Daniele Massera, Mark V Sherrid
|Sep 26, 2025
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.Olives Nguyen, Jack Wiedrick, Daniele Massera
|Sep 22, 2025
Treatment Response to Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy: 96-Week Results From the EXPLORER Cohort of the MAVA-Long-Term Extension Cardiac Magnetic Resonance Imaging Substudy.Sara Saberi, Christopher M Kramer, Artur Oręziak
|Jul 17, 2025
Mavacamten in Symptomatic Patients Resistant to Previous Advanced Therapy for Obstructive Hypertrophic Cardiomyopathy.Daniele Massera, Elizabeth Adlestein, Sumar Frejat
Pageof 4
Frequent Collaborators
8 joint publications
Daniele Massera
7 joint publications
Anjali Tiku Owens
6 joint publications
Sara Saberi
6 joint publications
Andrew Wang
5 joint publications
Paul C Cremer
5 joint publications
Srihari S Naidu
5 joint publications
Neal Lakdawala
5 joint publications
Steven E Nissen
4 joint publications
Milind Y Desai
4 joint publications
Amy J Sehnert
